Asthma biomarkers not yet fully adopted in daily practice

Despite the growing body of research on the use of biomarkers to guide asthma treatment, clinicians are still resistant to their use in daily practice, research shows. A survey of Australian members of the TSANZ Asthma Special Interest Group found only 53% of the 17 respondents were using or would like to use biomarkers to ...

Already a member?

Login to keep reading.

© 2021 the limbic